Onconetix, Inc. Defined Benefit Plan, Funded (Unfunded) Status of Plan
Onconetix, Inc. (ONCO) had Defined Benefit Plan, Funded (Unfunded) Status of Plan of -$73.64 thousand as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Funded (Unfunded) Status of Plan
us-gaap:DefinedBenefitPlanFundedStatusOfPlan · last filed 2026-03-13
- 2025-06-30: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$73.64K.
- 2025-03-31: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$219.16K.
- 2024-12-31: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$280.88K.
- 2023-12-31: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$556.30K.
| Period end | Defined Benefit Plan, Funded (Unfunded) Status of Plan |
|---|---|
| 2025-06-30 | -$73.64K 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$219.16K 10-Q · filed 2025-06-12 |
| 2024-12-31 | -$280.88K 10-K · filed 2026-03-13 |
| 2023-12-31 | -$556.30K 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |